Pioneura Corporation
Pioneura Corporation, based in Fairport, NY, is dedicated to transforming the treatment of Parkinson's disease, which is the fastest-growing neurodegenerative disease affecting over one million patients in the U.S. each year. The company's mission focuses on stopping cognitive decline and improving motor function in patients diagnosed with this debilitating condition.
At the core of Pioneura's innovative approach is URMC099, a novel anti-inflammatory compound designed to target a specific cellular pathway. By inhibiting key proteins, URMC099 aims to reverse neuroinflammation and prevent neuron cell death, ultimately enhancing the quality of life for those affected by Parkinson's disease.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
